Generalized Morphea Clinical Trial
— MORPHEAOfficial title:
Adult-onset Generalized Morphea : A Retrospective Multicenter Study
| NCT number | NCT04264728 |
| Other study ID # | 7551 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 1, 2019 |
| Est. completion date | April 2020 |
This study aimed to describe the demographical and clinical characteristics of a retrospective cohort of adult-onset GM and to investigate whether these findings differ between patients with an isomorphic and a symmetric pattern of lesion distribution.
| Status | Recruiting |
| Enrollment | 100 |
| Est. completion date | April 2020 |
| Est. primary completion date | April 2020 |
| Accepts healthy volunteers | |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Age of onset = 18 years - Patients with generalized morphea as defined by criteria established by Laxer and Zulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency to confluence and involve at least 2 different anatomic sites) - Availability of good-quality clinical photographs - Patient who, after being informed, has not expressed his or her opposition to the re-use of his or her data for the purposes of this research Exclusion Criteria: - Patients with linear morphea who met criteria for generalized morphea - Patient's opposition to participate |
| Country | Name | City | State |
|---|---|---|---|
| France | Service de dermatologie - Hôpital Civil de Strasbourg | Strasbourg |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Strasbourg, France |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Retrospective study of generalized morphea in adult patients consulted in dermatology departments | Files analyzed retrospectily from January 1st, 2019 to September 30, 2019 will be examined |